Form 4: Regulus Therapeutics Director Jason Nunn Receives Stock Grant

Director Jason Nunn of Regulus Therapeutics Inc. was granted 62,500 restricted stock units on April 30, 2025, vesting monthly over 12 months.

Summary

• Jason Nunn, a director at Regulus Therapeutics Inc., received a grant of 62,500 Restricted Stock Units (RSUs) on April 30, 2025.
• The RSUs will vest in equal monthly installments over a 12-month period from the grant date.

Sentiment

Score: 5

Explanation: The document is a routine disclosure of stock options granted to a director, with no inherent positive or negative sentiment.

Positives

• The grant of RSUs to a director aligns their interests with those of the shareholders.

Industry Context

Stock grants are a common form of compensation for directors and executives in publicly traded companies, aligning their interests with shareholders and incentivizing performance.

Stakeholder Impact

• The RSU grant could potentially incentivize the director to work towards increasing shareholder value.

Key Dates

Keywords

Regulus Therapeutics, RGLS, Jason Nunn, Restricted Stock Units, RSUs, Director, Stock Grant, Vesting